Common research protocols frequently investigate: 2.3mg once daily (10 units) 5 days weekly with 2 rest days More intensive protocols may investigate 2.3mg twice daily in advanced research settings Because Glow Blend contains GHK-Cu, many research protocols commonly include: Daily zinc supplementation Daily vitamin C supplementation to support collagen-related, antioxidant-support, skin-integrity, and regenerative research pathways while helping maintain copper and zinc balance in some research settings
The peptide apparently also reduced the depth of wrinkles while potentially increasing skin density and thickness after 12 weeks of experimentation in skin cell models with varying degrees of photodamage
The use of GHK-Cu has not been established in pediatric, pregnant, and breastfeeding individuals
Contact us today to schedule an initial consultation
In some cases, the drugs contain impurities
First identified in 1973 by researcher Loren Pickart, this peptide is naturally present in human plasma, saliva, and urine